Financial Performance - The company's operating revenue for 2022 was ¥1,607,967,046.25, representing a 29.48% increase compared to ¥1,241,841,376.13 in 2021[21]. - The net profit attributable to shareholders for 2022 was ¥169,522,792.62, a 7.84% increase from ¥157,201,759.69 in 2021[21]. - The net profit after deducting non-recurring gains and losses was ¥136,761,207.00, a decrease of 7.14% from ¥147,281,361.09 in 2021[21]. - The total assets at the end of 2022 were ¥2,874,611,893.48, a 66.97% increase from ¥1,721,685,294.74 at the end of 2021[21]. - The net assets attributable to shareholders at the end of 2022 were ¥2,370,467,383.42, up 107.25% from ¥1,143,797,273.60 at the end of 2021[21]. - The basic earnings per share for 2022 was ¥0.45, a 2.27% increase from ¥0.44 in 2021[21]. - The weighted average return on equity decreased to 10.73% in 2022 from 14.76% in 2021, reflecting a decline of 4.03%[21]. - The company reported a total revenue of 1.2 billion RMB for the year 2022, representing a year-over-year increase of 15%[139]. - The company reported a total revenue of 1.5 billion RMB for the fiscal year 2022, representing a year-over-year increase of 12%[151]. Cash Flow and Dividends - The company plans to distribute a cash dividend of 0.37 RMB per 10 shares to all shareholders, based on a total of 420,000,000 shares[4]. - The company proposed a cash dividend of CNY 0.37 per 10 shares, amounting to a total cash dividend of CNY 15.54 million, which represents 100% of the profit distribution[180]. - The company's operating cash inflow for 2022 was CNY 1,500,245,711.43, an increase of 28.51% compared to 2021[80]. - The net cash flow from operating activities was negative CNY 31,277,474.53, a decrease of 139.01% year-on-year[80]. Market Position and Growth - The global aseptic packaging market size in 2022 was approximately 486.6 billion packages, with an expected compound annual growth rate of 3.4% over the next three years[32]. - The Chinese aseptic packaging market reached a scale of 113.6 billion packages in 2022, with a sales growth rate of 8.3% from 2018 to 2021[33]. - In 2022, the company captured approximately 10.1% of the Chinese sterile packaging market and 13.3% of the liquid milk market share[35]. - The liquid milk market in China grew by 5% in 2022 compared to 2021, indicating a steady demand for sterile packaging[49]. - The company aims to enhance its market penetration through domestic substitution and incremental consumption in the liquid dairy market[35]. - The company plans to expand its market presence in Southeast Asia, targeting a 30% increase in market share by 2025[142]. Production and Technology - The company's production capacity increased from 10.5 billion packages to 18 billion packages, representing a growth of 71.43%[63]. - The company has accumulated over 28 core technologies focused on improving the efficiency and stability of sterile packaging production[56]. - The company has obtained 22 patents for its core technologies as of the end of the reporting period[57]. - The company is focusing on automation and intelligent upgrades in production and warehousing to improve efficiency and reduce operational costs[51]. - The company employs a "make-to-order" production model, ensuring efficient production based on customer demand[46]. - The company is investing 100 million RMB in R&D for new technologies aimed at improving production efficiency by 15%[142]. - The company is investing 200 million RMB in R&D for new technologies aimed at enhancing production efficiency and sustainability[151]. Risk Management and Compliance - The company emphasizes the importance of risk awareness regarding future plans and performance forecasts, indicating that these do not constitute commitments to investors[4]. - The company has outlined potential risks and corresponding countermeasures in its management discussion section[4]. - The company has established a comprehensive internal control management organization to oversee risk management[187]. - There were no financial report significant defects or important defects identified during the reporting period[190]. - The company has adhered to legal regulations and internal control systems to ensure compliance and asset security[186]. Corporate Governance - The company has established a governance structure including a shareholders' meeting, board of directors, and supervisory board to ensure compliance and operational efficiency[121]. - The company has implemented a performance evaluation and incentive system for directors, supervisors, and senior management, ensuring transparency and adherence to legal standards[127]. - The total remuneration paid to the board of directors, supervisors, and senior management for the year 2022 amounted to 8.6127 million yuan[161]. - The board of directors held a total of 8 meetings during the reporting period, with all members present at each meeting[165]. Environmental Responsibility - The company has implemented environmental protection measures in compliance with local regulations, with valid pollution discharge permits until July 30, 2023[194]. - The company reported a wastewater discharge of 34.5 mg/m³ for COD, which is below the standard limit of 100 mg/m³[197]. - The company operates a VOCs catalytic combustion treatment facility with a capacity of 70,000 m³/h, which is functioning normally[197]. - The company aims to continue improving its internal control system to ensure sustainable and healthy development[187]. - The company has established a carbon reduction strategy in line with the "dual carbon" goals, focusing on minimizing environmental impact throughout the product lifecycle[198]. Employee Development - The company has a comprehensive training system focusing on digital training to enhance employee capabilities and establish a talent pipeline[175]. - The company has implemented a stock incentive plan, which was approved by the board and aims to align employee interests with company performance[182]. - The total number of employees at the end of the reporting period is 529, with 326 in the parent company and 203 in major subsidiaries[172]. - The professional composition includes 271 production personnel, 49 sales personnel, 36 technical personnel, 18 financial personnel, 121 administrative personnel, and 34 procurement personnel[172].

证券代码：301296 证券简称：新巨丰 公告编号：2023-039 山东新巨丰科技包装股份有限公司 关于举办2022年度业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有任 何虚假记载、误导性陈述或重大遗漏。 重要内容提示： 山东新巨丰科技包装股份有限公司（以下简称"公司"）已于 2023 年 4 月 20 日在巨潮资讯网上披露了《2022 年年度报告全文》及《2022 年年度报告摘要》。 为便于广大投资者更加全面深入地了解公司经营业绩、发展战略等情况，公司定 于 2023 年 05 月 08 日（星期一）15:30-17:00 在"价值在线"（www.ir-online.cn） 举办山东新巨丰科技包装股份有限公司 2022 年度业绩说明会，与投资者进行沟 通和交流，广泛听取投资者的意见和建议。 会议召开时间：2023 年 05 月 08 日（星期一）15:30-17:00 会议召开地点：价值在线（www.ir-online.cn） 会议召开方式：网络互动方式 二、参加人员 董事长：袁训军 财务负责人：马仁强 独立董事：陈学军 副总经理、董事会秘书：徐雅卉 （如遇特殊情况，参会 ...

证券代码：301296 证券简称：新巨 丰 山东新巨丰科技包装股份有限公司投资者关系活动记录表 | --- | --- | --- | --- | --- | --- | |---------------|-------------------|-------------|----------------------------|-------------|-----------------| | | | | | | 编号： 2022-001 | | 投资者 关系活 | | | 特定对象调研 □分析师会议 | | | | 动类别 | | | □媒体采访 □业绩说明会 | | | | | □新闻发布会 | | □路演活动 | | | | | □现场参观 | | | | | | | □其他 | | （请文字说明其他活动内容） | | | | 参与单 位名称 | 银华基金 李晓星 | | | | | | 及人员姓名 | 拾贝投资 李昌强 | 练强 | | | | | | 华泰柏瑞 彭邦泰 | | | | | | | 中信证券 | 李晨阳 汪达 | | 魏喆 朱雅仪 | | | | 东兴基金 高坤 | | | | | ...

Financial Performance - The company's revenue for Q3 2022 reached ¥426,659,752.32, representing a year-on-year increase of 27.76%[5] - Net profit attributable to shareholders for Q3 2022 was ¥50,276,691.32, up 35.80% compared to the same period last year[5] - The company's total revenue for the first nine months of 2022 was ¥1,122,168,059.79, a 30.13% increase from ¥862,318,787.18 in the same period of 2021[11] - Total operating revenue for the period reached CNY 1,122,168,059.79, an increase of 30.2% compared to CNY 862,318,787.18 in the previous period[24] - Net profit for the period was CNY 121,809,221.09, representing a 4.8% increase from CNY 117,142,771.33 in the same period last year[25] Assets and Liabilities - The total assets as of September 30, 2022, amounted to ¥2,985,523,103.89, reflecting a 72.79% increase from the end of the previous year[5] - The company's total assets increased to CNY 2,985,523,103.89, compared to CNY 1,727,848,678.24 in the previous year, reflecting a growth of 72.8%[23] - Total liabilities rose to CNY 664,204,827.74, an increase of 13.7% from CNY 584,051,404.64 year-over-year[23] - The equity attributable to shareholders of the parent company reached CNY 2,321,318,276.15, up 102.1% from CNY 1,143,797,273.60 in the previous year[23] Cash Flow - The net cash flow from operating activities for the year-to-date period increased by 221.91% to ¥71,349,356.64[5] - The net cash flow from operating activities for the first nine months of 2022 was RMB 71,349,356.64, an increase of 221.91% compared to RMB 22,164,471.06 in the same period of 2021[15] - Operating cash flow for the period was CNY 71,349,356.64, a significant increase from CNY 22,164,471.06 in the previous period, reflecting a growth of approximately 221%[26] - Net cash flow from financing activities surged to RMB 1,095,101,957.00, a dramatic increase of 15801.42% from RMB 6,886,819.90 in the prior year[15] - The company reported a net increase in cash and cash equivalents of CNY 1,160,334,401.07, compared to a decrease of CNY 98,304,821.43 in the same period last year[27] Shareholder Information - The total number of common shareholders at the end of the reporting period was 36,844[15] - The largest shareholder, Beijing Jingjufeng Energy Control Equipment Co., Ltd., held 22.56% of the shares, totaling 94,764,543 shares[15] - The company reported a total of 360,846,568 restricted shares at the end of the period, with no new shares issued during the quarter[19] - The company has several shareholders with significant restricted shares, including Beijing Jingjufeng Energy Control Equipment Co., Ltd. holding 94,764,543 shares[19] Operational Insights - The company reported significant increases in operating income due to a substantial rise in sales volume[16] - Operating costs rose primarily due to increased production costs associated with higher sales volume[16] - The company achieved substantial investment income from foreign exchange hedging activities during the period[16] - Other income increased due to higher government subsidies received in the current period[16] - The company is committed to enhancing its operational efficiency and exploring potential mergers and acquisitions to drive future growth[20] Investment and R&D - The company reported an investment income of ¥4,207,431.81 for the first nine months of 2022, a substantial increase of 3608.80% compared to the previous year[11] - Research and development expenses for the period were CNY 7,231,478.69, a slight increase from CNY 6,309,336.89 in the previous year[24] - The company has a strong focus on expanding its market presence and enhancing product offerings through ongoing research and development initiatives[16] - The company plans to maintain its focus on expanding its market presence and developing new technologies in the upcoming quarters[20] Current Assets - Cash and cash equivalents increased by 361.55% to ¥1,600,402,655.82 as of September 30, 2022, compared to ¥346,744,730.70 at the beginning of the year[9] - Total current assets reached ¥2,401,109,404.47, up from ¥1,128,115,989.08 at the start of the year, indicating an increase of about 112.5%[21] - Accounts receivable rose to ¥362,019,412.21 from ¥350,930,421.36, showing a slight increase of approximately 3.1%[21] - Inventory increased to ¥216,482,955.64 from ¥185,576,184.21, reflecting a growth of around 16.7%[21] - Total amount of other receivables increased to ¥3,445,223.05 from ¥1,193,571.78, marking a growth of approximately 188.8%[21]